Your Shopping Cart Is Empty
| Report Code: A13936 | Pages: NA | ||
| Tables: NA | Charts: NA |
| |
Biomarkers are used for various purposes such as disease diagnosis, prognosis, prediction, and assessment of treatment response. Diagnostic biomarkers have early inferences for the detection of patent ductus arteriosus (PDA). Predictive markers provide personalized treatment regimens and prognostic markers predict patient survival and recurrence patterns.
Biomarkers are used for clinical diagnostics for detecting multiple diseases, for instance, creatinine for diagnosing renal insufficiency, troponin level for diagnosing myocardial infarction, and amylase for pancreatitis. Biomarkers provide an approach in understanding the dynamics of neurological disease with the contribution in applications of analytical epidemiology and clinical trials. Diagnostic biomarkers can extend the base of information of the underlying pathology of disease along with providing means for homogeneous classification of a disease's possible factors that are a risk for the body.
COVID-19 Impact analysis
Top Impacting Factors
High prevalence of cancer and other chronic disorders is the key driver for market growth.
Increasing diagnostic applications of biomarkers and rising R&D funding for pharma and biotech companies are few factors responsible for propelling the diagnostic biomarkers market growth.
Moreover, low cost of clinical trials in developing countries and new initiatives for research contribute toward the growth of the global diagnostic biomarkers market.
Biomarkers are prominently used in application areas such as personalized medicines, companion diagnostics, and other diagnostic areas, including drug discovery & development and disease risk assessment. These increasing diagnostic applications of biomarkers are expected to drive market growth in the forecasted years.
Advancements in laboratory techniques and expansion of the molecular biology sector are other key factors stimulating the growth of the diagnostic biomarker market.
On the other hand, poorly suited regulatory and reimbursement systems, high capital investments, low cost-benefit ratio, and technical issues related to sample collection & storage are the major factors restraining the growth of this market.
Market Trends
New product launches to flourish the market
Surge in usage due to cancer
Key Benefits of the Report
Questions answered in the Diagnostic Biomarkers Report
Diagnostic Biomarkers Market Report Highlights
| Aspects | Details |
|---|---|
| By Product Type |
|
| By Application |
|
| By End User |
|
| By Region |
|
| Key Market Players | Biosims Technologies Sas, Enzo Biochem, Inc., Bio-Rad Laboratories, Inc., EKF Diagnostics Holdings, Inc., Perkinelmer, Inc., Cisbio Bioassays, Merck Millipore, Qiagen N.V., Signosis, Inc, Banyan Biomarkers, Inc,, Biomedical Corp., Meso Scale Diagnostics, LLC. |
Loading Table Of Content...
Start reading.
This Report and over 71,215+ more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
15%
Discount
15%
Discount
Enterprise
License/PDF
20%
Discount
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report
